Proposed Standardized Neurological Endpoints for Cardiovascular Clinical Trials

Alexandra J. Lansky, Steven R. Messé, Adam M. Brickman, Michael Dwyer, H. Bart Van Der Worp, Ronald M. Lazar, Cody G. Pietras, Kevin J. Abrams, Eugene McFadden, Nils H. Petersen, Jeffrey Browndyke, Bernard Prendergast, Vivian G. Ng, Donald E. Cutlip, Samir Kapadia, Mitchell W. Krucoff, Axel Linke, Claudia Scala Moy, Joachim Schofer, Gerrit Anne Van Es & 17 others Renu Virmani, Jeffrey Popma, Michael K. Parides, Susheel Kodali, Michel Bilello, Robert Zivadinov, Joseph Akar, Karen L. Furie, Daryl Gress, Szilard Voros, Jeffrey Moses, David Greer, John K. Forrest, David Holmes, Arie P. Kappetein, Michael Mack, Andreas Baumbach

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Surgical and catheter-based cardiovascular procedures and adjunctive pharmacology have an inherent risk of neurological complications. The current diversity of neurological endpoint definitions and ascertainment methods in clinical trials has led to uncertainties in the neurological risk attributable to cardiovascular procedures and inconsistent evaluation of therapies intended to prevent or mitigate neurological injury. Benefit-risk assessment of such procedures should be on the basis of an evaluation of well-defined neurological outcomes that are ascertained with consistent methods and capture the full spectrum of neurovascular injury and its clinical effect. The Neurologic Academic Research Consortium is an international collaboration intended to establish consensus on the definition, classification, and assessment of neurological endpoints applicable to clinical trials of a broad range of cardiovascular interventions. Systematic application of the proposed definitions and assessments will improve our ability to evaluate the risks of cardiovascular procedures and the safety and effectiveness of preventive therapies.

Original languageEnglish (US)
Pages (from-to)1687-1697
Number of pages11
JournalEuropean Heart Journal
Volume39
Issue number19
DOIs
StatePublished - May 14 2018
Externally publishedYes

Fingerprint

Clinical Trials
Wounds and Injuries
Nervous System
Uncertainty
Catheters
Pharmacology
Safety
Therapeutics
Research

Keywords

  • cardiovascular
  • methodology
  • neurological definitions
  • outcomes
  • stroke
  • trials

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Lansky, A. J., Messé, S. R., Brickman, A. M., Dwyer, M., Bart Van Der Worp, H., Lazar, R. M., ... Baumbach, A. (2018). Proposed Standardized Neurological Endpoints for Cardiovascular Clinical Trials. European Heart Journal, 39(19), 1687-1697. https://doi.org/10.1093/eurheartj/ehx037

Proposed Standardized Neurological Endpoints for Cardiovascular Clinical Trials. / Lansky, Alexandra J.; Messé, Steven R.; Brickman, Adam M.; Dwyer, Michael; Bart Van Der Worp, H.; Lazar, Ronald M.; Pietras, Cody G.; Abrams, Kevin J.; McFadden, Eugene; Petersen, Nils H.; Browndyke, Jeffrey; Prendergast, Bernard; Ng, Vivian G.; Cutlip, Donald E.; Kapadia, Samir; Krucoff, Mitchell W.; Linke, Axel; Scala Moy, Claudia; Schofer, Joachim; Van Es, Gerrit Anne; Virmani, Renu; Popma, Jeffrey; Parides, Michael K.; Kodali, Susheel; Bilello, Michel; Zivadinov, Robert; Akar, Joseph; Furie, Karen L.; Gress, Daryl; Voros, Szilard; Moses, Jeffrey; Greer, David; Forrest, John K.; Holmes, David; Kappetein, Arie P.; Mack, Michael; Baumbach, Andreas.

In: European Heart Journal, Vol. 39, No. 19, 14.05.2018, p. 1687-1697.

Research output: Contribution to journalArticle

Lansky, AJ, Messé, SR, Brickman, AM, Dwyer, M, Bart Van Der Worp, H, Lazar, RM, Pietras, CG, Abrams, KJ, McFadden, E, Petersen, NH, Browndyke, J, Prendergast, B, Ng, VG, Cutlip, DE, Kapadia, S, Krucoff, MW, Linke, A, Scala Moy, C, Schofer, J, Van Es, GA, Virmani, R, Popma, J, Parides, MK, Kodali, S, Bilello, M, Zivadinov, R, Akar, J, Furie, KL, Gress, D, Voros, S, Moses, J, Greer, D, Forrest, JK, Holmes, D, Kappetein, AP, Mack, M & Baumbach, A 2018, 'Proposed Standardized Neurological Endpoints for Cardiovascular Clinical Trials', European Heart Journal, vol. 39, no. 19, pp. 1687-1697. https://doi.org/10.1093/eurheartj/ehx037
Lansky AJ, Messé SR, Brickman AM, Dwyer M, Bart Van Der Worp H, Lazar RM et al. Proposed Standardized Neurological Endpoints for Cardiovascular Clinical Trials. European Heart Journal. 2018 May 14;39(19):1687-1697. https://doi.org/10.1093/eurheartj/ehx037
Lansky, Alexandra J. ; Messé, Steven R. ; Brickman, Adam M. ; Dwyer, Michael ; Bart Van Der Worp, H. ; Lazar, Ronald M. ; Pietras, Cody G. ; Abrams, Kevin J. ; McFadden, Eugene ; Petersen, Nils H. ; Browndyke, Jeffrey ; Prendergast, Bernard ; Ng, Vivian G. ; Cutlip, Donald E. ; Kapadia, Samir ; Krucoff, Mitchell W. ; Linke, Axel ; Scala Moy, Claudia ; Schofer, Joachim ; Van Es, Gerrit Anne ; Virmani, Renu ; Popma, Jeffrey ; Parides, Michael K. ; Kodali, Susheel ; Bilello, Michel ; Zivadinov, Robert ; Akar, Joseph ; Furie, Karen L. ; Gress, Daryl ; Voros, Szilard ; Moses, Jeffrey ; Greer, David ; Forrest, John K. ; Holmes, David ; Kappetein, Arie P. ; Mack, Michael ; Baumbach, Andreas. / Proposed Standardized Neurological Endpoints for Cardiovascular Clinical Trials. In: European Heart Journal. 2018 ; Vol. 39, No. 19. pp. 1687-1697.
@article{5143dee45e364f04a166bac1b2ec35d5,
title = "Proposed Standardized Neurological Endpoints for Cardiovascular Clinical Trials",
abstract = "Surgical and catheter-based cardiovascular procedures and adjunctive pharmacology have an inherent risk of neurological complications. The current diversity of neurological endpoint definitions and ascertainment methods in clinical trials has led to uncertainties in the neurological risk attributable to cardiovascular procedures and inconsistent evaluation of therapies intended to prevent or mitigate neurological injury. Benefit-risk assessment of such procedures should be on the basis of an evaluation of well-defined neurological outcomes that are ascertained with consistent methods and capture the full spectrum of neurovascular injury and its clinical effect. The Neurologic Academic Research Consortium is an international collaboration intended to establish consensus on the definition, classification, and assessment of neurological endpoints applicable to clinical trials of a broad range of cardiovascular interventions. Systematic application of the proposed definitions and assessments will improve our ability to evaluate the risks of cardiovascular procedures and the safety and effectiveness of preventive therapies.",
keywords = "cardiovascular, methodology, neurological definitions, outcomes, stroke, trials",
author = "Lansky, {Alexandra J.} and Mess{\'e}, {Steven R.} and Brickman, {Adam M.} and Michael Dwyer and {Bart Van Der Worp}, H. and Lazar, {Ronald M.} and Pietras, {Cody G.} and Abrams, {Kevin J.} and Eugene McFadden and Petersen, {Nils H.} and Jeffrey Browndyke and Bernard Prendergast and Ng, {Vivian G.} and Cutlip, {Donald E.} and Samir Kapadia and Krucoff, {Mitchell W.} and Axel Linke and {Scala Moy}, Claudia and Joachim Schofer and {Van Es}, {Gerrit Anne} and Renu Virmani and Jeffrey Popma and Parides, {Michael K.} and Susheel Kodali and Michel Bilello and Robert Zivadinov and Joseph Akar and Furie, {Karen L.} and Daryl Gress and Szilard Voros and Jeffrey Moses and David Greer and Forrest, {John K.} and David Holmes and Kappetein, {Arie P.} and Michael Mack and Andreas Baumbach",
year = "2018",
month = "5",
day = "14",
doi = "10.1093/eurheartj/ehx037",
language = "English (US)",
volume = "39",
pages = "1687--1697",
journal = "European Heart Journal",
issn = "0195-668X",
publisher = "Oxford University Press",
number = "19",

}

TY - JOUR

T1 - Proposed Standardized Neurological Endpoints for Cardiovascular Clinical Trials

AU - Lansky, Alexandra J.

AU - Messé, Steven R.

AU - Brickman, Adam M.

AU - Dwyer, Michael

AU - Bart Van Der Worp, H.

AU - Lazar, Ronald M.

AU - Pietras, Cody G.

AU - Abrams, Kevin J.

AU - McFadden, Eugene

AU - Petersen, Nils H.

AU - Browndyke, Jeffrey

AU - Prendergast, Bernard

AU - Ng, Vivian G.

AU - Cutlip, Donald E.

AU - Kapadia, Samir

AU - Krucoff, Mitchell W.

AU - Linke, Axel

AU - Scala Moy, Claudia

AU - Schofer, Joachim

AU - Van Es, Gerrit Anne

AU - Virmani, Renu

AU - Popma, Jeffrey

AU - Parides, Michael K.

AU - Kodali, Susheel

AU - Bilello, Michel

AU - Zivadinov, Robert

AU - Akar, Joseph

AU - Furie, Karen L.

AU - Gress, Daryl

AU - Voros, Szilard

AU - Moses, Jeffrey

AU - Greer, David

AU - Forrest, John K.

AU - Holmes, David

AU - Kappetein, Arie P.

AU - Mack, Michael

AU - Baumbach, Andreas

PY - 2018/5/14

Y1 - 2018/5/14

N2 - Surgical and catheter-based cardiovascular procedures and adjunctive pharmacology have an inherent risk of neurological complications. The current diversity of neurological endpoint definitions and ascertainment methods in clinical trials has led to uncertainties in the neurological risk attributable to cardiovascular procedures and inconsistent evaluation of therapies intended to prevent or mitigate neurological injury. Benefit-risk assessment of such procedures should be on the basis of an evaluation of well-defined neurological outcomes that are ascertained with consistent methods and capture the full spectrum of neurovascular injury and its clinical effect. The Neurologic Academic Research Consortium is an international collaboration intended to establish consensus on the definition, classification, and assessment of neurological endpoints applicable to clinical trials of a broad range of cardiovascular interventions. Systematic application of the proposed definitions and assessments will improve our ability to evaluate the risks of cardiovascular procedures and the safety and effectiveness of preventive therapies.

AB - Surgical and catheter-based cardiovascular procedures and adjunctive pharmacology have an inherent risk of neurological complications. The current diversity of neurological endpoint definitions and ascertainment methods in clinical trials has led to uncertainties in the neurological risk attributable to cardiovascular procedures and inconsistent evaluation of therapies intended to prevent or mitigate neurological injury. Benefit-risk assessment of such procedures should be on the basis of an evaluation of well-defined neurological outcomes that are ascertained with consistent methods and capture the full spectrum of neurovascular injury and its clinical effect. The Neurologic Academic Research Consortium is an international collaboration intended to establish consensus on the definition, classification, and assessment of neurological endpoints applicable to clinical trials of a broad range of cardiovascular interventions. Systematic application of the proposed definitions and assessments will improve our ability to evaluate the risks of cardiovascular procedures and the safety and effectiveness of preventive therapies.

KW - cardiovascular

KW - methodology

KW - neurological definitions

KW - outcomes

KW - stroke

KW - trials

UR - http://www.scopus.com/inward/record.url?scp=85047073803&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85047073803&partnerID=8YFLogxK

U2 - 10.1093/eurheartj/ehx037

DO - 10.1093/eurheartj/ehx037

M3 - Article

VL - 39

SP - 1687

EP - 1697

JO - European Heart Journal

JF - European Heart Journal

SN - 0195-668X

IS - 19

ER -